199 related articles for article (PubMed ID: 18986330)
1. Quercetin activates human Kv1.5 channels by a residue I502 in the S6 segment.
Yang L; Ma JH; Zhang PH; Zou AR; Tu DN
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):154-61. PubMed ID: 18986330
[TBL] [Abstract][Full Text] [Related]
2. Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain.
Duan JJ; Ma JH; Zhang PH; Wang XP; Zou AR; Tu DN
Acta Pharmacol Sin; 2007 Jul; 28(7):959-67. PubMed ID: 17588331
[TBL] [Abstract][Full Text] [Related]
3. Interaction of propofol with voltage-gated human Kv1.5 channel through specific amino acids within the pore region.
Kojima A; Ito Y; Ding WG; Kitagawa H; Matsuura H
Eur J Pharmacol; 2015 Oct; 764():622-632. PubMed ID: 26256861
[TBL] [Abstract][Full Text] [Related]
4. Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 currents independently of lipoxygenase.
Gong YZ; Ding WG; Wu J; Tsuji K; Horie M; Matsuura H
Eur J Pharmacol; 2008 Dec; 600(1-3):18-25. PubMed ID: 18930721
[TBL] [Abstract][Full Text] [Related]
5. Kvbeta1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels.
Arias C; Guizy M; David M; Marzian S; González T; Decher N; Valenzuela C
Anesthesiology; 2007 Oct; 107(4):641-51. PubMed ID: 17893461
[TBL] [Abstract][Full Text] [Related]
6. Human glycine alpha1 receptor inhibition by quercetin is abolished or inversed by alpha267 mutations in transmembrane domain 2.
Lee BH; Lee JH; Yoon IS; Lee JH; Choi SH; Pyo MK; Jeong SM; Choi WS; Shin TJ; Lee SM; Rhim H; Park YS; Han YS; Paik HD; Cho SG; Kim CH; Lim YH; Nah SY
Brain Res; 2007 Aug; 1161():1-10. PubMed ID: 17603028
[TBL] [Abstract][Full Text] [Related]
7. The membrane permeable calcium chelator BAPTA-AM directly blocks human ether a-go-go-related gene potassium channels stably expressed in HEK 293 cells.
Tang Q; Jin MW; Xiang JZ; Dong MQ; Sun HY; Lau CP; Li GR
Biochem Pharmacol; 2007 Dec; 74(11):1596-607. PubMed ID: 17826747
[TBL] [Abstract][Full Text] [Related]
8. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.
Caballero R; Gómez R; Núñez L; Moreno I; Tamargo J; Delpón E
Cardiovasc Res; 2004 Dec; 64(3):457-66. PubMed ID: 15537499
[TBL] [Abstract][Full Text] [Related]
9. Electropharmacological properties of telmisartan in blocking hKv1.5 and HERG potassium channels expressed on Xenopus laevis oocytes.
Tu DN; Liao YH; Zou AR; Du YM; Run Q; Wang XP; Li L
Acta Pharmacol Sin; 2008 Aug; 29(8):913-22. PubMed ID: 18664324
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory actions of the phosphatidylinositol 3-kinase inhibitor LY294002 on the human Kv1.5 channel.
Wu J; Ding WG; Matsuura H; Tsuji K; Zang WJ; Horie M
Br J Pharmacol; 2009 Jan; 156(2):377-87. PubMed ID: 19154427
[TBL] [Abstract][Full Text] [Related]
11. Acacetin causes a frequency- and use-dependent blockade of hKv1.5 channels by binding to the S6 domain.
Wu HJ; Wu W; Sun HY; Qin GW; Wang HB; Wang P; Yalamanchili HK; Wang J; Tse HF; Lau CP; Vanhoutte PM; Li GR
J Mol Cell Cardiol; 2011 Dec; 51(6):966-73. PubMed ID: 21906601
[TBL] [Abstract][Full Text] [Related]
12. High extracellular potassium ion concentration attenuates the blockade action of ketanserin on Kv1.3 channels expressed in xenopus oocytes.
Liang ZT; Wang XP; Zeng QT; Liao YH; Zou AR; Li L; Tu DN
Chin Med J (Engl); 2008 Dec; 121(24):2584-91. PubMed ID: 19187600
[TBL] [Abstract][Full Text] [Related]
13. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
Lagrutta A; Wang J; Fermini B; Salata JJ
J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for competition between drug binding and Kvbeta 1.3 accessory subunit-induced N-type inactivation of Kv1.5 channels.
Decher N; Kumar P; Gonzalez T; Renigunta V; Sanguinetti MC
Mol Pharmacol; 2005 Oct; 68(4):995-1005. PubMed ID: 16024663
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of Kv1.5 channel block by diphenyl phosphine oxide-1.
Du YM; Zhang XX; Tu DN; Zhao N; Liu YJ; Xiao H; Sanguinetti MC; Zou A; Liao YH
J Mol Cell Cardiol; 2010 Jun; 48(6):1111-20. PubMed ID: 20184887
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity of voltage-gated potassium channels Kv1.5 and Kv1.2 to acidic pH and molecular identification of pH sensor.
Steidl JV; Yool AJ
Mol Pharmacol; 1999 May; 55(5):812-20. PubMed ID: 10220559
[TBL] [Abstract][Full Text] [Related]
17. Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5.
Perchenet L; Hilfiger L; Mizrahi J; Clément-Chomienne O
J Pharmacol Exp Ther; 2001 Sep; 298(3):1108-19. PubMed ID: 11504808
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism.
Núñez L; Vaquero M; Gómez R; Caballero R; Mateos-Cáceres P; Macaya C; Iriepa I; Gálvez E; López-Farré A; Tamargo J; Delpón E
Cardiovasc Res; 2006 Oct; 72(1):80-9. PubMed ID: 16876149
[TBL] [Abstract][Full Text] [Related]
19. Constitutive inactivation of the hKv1.5 mutant channel, H463G, in K+-free solutions at physiological pH.
Zhang S; Eduljee C; Kwan DC; Kehl SJ; Fedida D
Cell Biochem Biophys; 2005; 43(2):221-30. PubMed ID: 16049347
[TBL] [Abstract][Full Text] [Related]
20. A single residue in the S6 transmembrane domain governs the differential flecainide sensitivity of voltage-gated potassium channels.
Herrera D; Mamarbachi A; Simoes M; Parent L; Sauvé R; Wang Z; Nattel S
Mol Pharmacol; 2005 Aug; 68(2):305-16. PubMed ID: 15883204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
